The company’s pharmaceutical business reported a 15 percent hike in sales compared to 2022’s first quarter. Its brand and specialty drugs drove most of the final sales numbers, which was $39.8 billion last year and $45.8 billion this quarter, according to Cardinal Health.
Its medical segment fell 9 percent from $4.1 billion to $3.8 billion, which the devicemaker said was “primarily due to PPE pricing and volumes.”
Cardinal Health also attributed part of the loss to less investment in its Cordis business, a cardiology and endovascular device business it bought from Johnson & Johnson in 2015 for nearly $2 billion. Cardinal then sold it in 2021 for about $1 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
